Cancer Res Commun
Antibodies, Monoclonal, HumanizedCarcinoma, Renal CellKidney Neoplasms
Dr. Geetika Srivastava, MD
NPI1720296320
- Medicare services, 2022
- 137
- Part D claims, 2022
- 52
- Publications
- 6
- Clinical trials
- 2
- Hospital affiliations
- 1
- Practice address
- 50 Irving Street N.W., Washington, DC 20422
- Practice phone
- Call (202) 745-8000
- Professional email
- Get professional email
- Personal email
- Get personal email
- Mobile number
- Get mobile number
Primary practice
Find Dr. Srivastava's professional email, personal email and mobile number
Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.
Dr. Geetika Srivastava is a hematologist and oncologist in Washington, District of Columbia
Dr. Srivastava practices at Washington DC VA Medical Center in Washington, District of Columbia, part of Veterans Health Administration.
Dr. Srivastava's NPI, 1720296320, was assigned on May 18, 2007. Dr. Srivastava holds Colorado license DR-52981.
NPI and contact details
- NPI
- 1720296320NPI Registry (opens in a new tab)
- NPI enumeration date
- May 18, 2007
- NPI status
- Active
- Practice phone
- (202) 745-8000
- Professional email
- Get email
- Personal email
- Get email
- Mobile number
- Get number
- Sex
- Female
- Estimated age
- 47
- Medical school graduation
- 2005
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Affiliation Data
Dr. Geetika Srivastava practices at Washington DC VA Medical Center in Washington, District of Columbia
Dr. Srivastava's primary practice is Washington DC VA Medical Center, at 50 Irving Street N.W., Washington, DC 20422 in The District County. The practice phone is (202) 745-8000.
- Washington DC VA Medical Center50 Irving Street N.W., Washington, DC 20422 · The District CountyPhone(202) 745-8000
Source: Dmand AI Affiliation Data
Dr. Geetika Srivastava is affiliated with 1 site of care
Dr. Srivastava's primary practice is Washington DC VA Medical Center in Washington, District of Columbia, part of Veterans Health Administration. Dr. Srivastava's employer is on file too: a hospital.
Sources: Dmand AI Affiliation Data; and Dmand AI Org Hierarchy Data
Dmand AI tracks the EHR system at Dr. Geetika Srivastava's practice
Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Srivastava practices. Vendor and product names are available with a free account.
| Site | EHR vendor and product |
|---|---|
| Washington DC VA Medical Center | Available with a free account |
Source: Dmand AI Technology Install Data
For health IT teams
See the EHR and IT leaders at every hospital where Dr. Srivastava practices
Dmand AI maps EHR vendors, IT decision makers and buying committees across Veterans Health Administration and 6.2K+ hospitals, with verified contacts in the same login.
Dr. Geetika Srivastava is one of 66 hematologists and oncologists in District of Columbia
Hematology and oncology is Dr. Srivastava's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Srivastava is licensed in Colorado.
Specialties and state licenses
- Hematology and oncology, ColoradoPrimary
Hematologists and oncologists near Dr. Srivastava
Counts of hematologists and oncologists with a Dmand AI profile, by place and practice. Each opens the list.
66hematologists and oncologists in District of Columbia66hematologists and oncologists in Washington5hematologists and oncologists at Washington DC VA Medical Center
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks
Dr. Geetika Srivastava billed Medicare for 137 services in 2022
CMS data shows 137 Medicare services from Dr. Srivastava across 4 procedure codes in 2022. Medicare paid $9,774 for them. Every service was in a facility, such as a hospital, rather than an office.
Medicare services, 2022137
Paid by Medicare$9,774
Procedure codes4
Dr. Srivastava's Medicare services by type, 2021 to 2022
- 2021
- 2022
- Office and hospital visits
- 2021: 6532022: 13779%
- Other services
- 2021: 242022: 0100%
Dr. Srivastava compared with the District of Columbia median for hematologists and oncologists, 2022
- Dr. Srivastava
- District of Columbia median
- Medicare services
- 137vs 39665% below
- Part D claims
- 52vs 11454% below
Medians across 62 hematologists and oncologists in District of Columbia with Dmand AI profiles that report each measure.
Dr. Srivastava's most billed Medicare procedure codes, 2022
CMS publishes codes billed for 11 or more Medicare patients. Each label is the code family; CPT descriptions are licensed by the AMA.
Need commercial claims for Dr. Srivastava?
Medicare shows one payer. Book a meeting to get commercial claims data for Dr. Srivastava and other hematologists and oncologists in District of Columbia.
Sources: Medicare Physician & Other Practitioners - by Provider and Service (CMS), 2024 data; and Dmand AI Peer Benchmarks
Dr. Geetika Srivastava's patients have a median age of 76
Across all payers, Dmand AI patient panel data puts Dr. Srivastava's median patient age at 76, with 44% women.
Dr. Srivastava's patients across all payers
Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.
Patient panel by age, all payers
Median age 76
Patient panel by sex, all payers
- Women44%
- Men56%
Source: Dmand AI Patient Panel Data
Dr. Geetika Srivastava wrote 52 Medicare Part D claims in 2022
In 2022, Dr. Srivastava wrote 52 Medicare Part D claims. Every claim was for a generic drug. They cover 2 drugs, with $1,645 in total drug cost. In 2021, CMS named 409 claims across 15 drugs.
Part D claims, 202252
Drugs named by CMS2
Total drug cost$1,645
Dr. Srivastava's most prescribed drugs by claims, 2022
CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.
Part D claims for drugs CMS names, 2021 to 2022
- 2021
- 2022
- Claims for drugs CMS names
- 2021: 4092022: 5287%
Drugs named by CMS: 2 in 2022, 15 in 2021.
Source: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026
For MedTech and pharma teams
Find hematologists and oncologists like Dr. Srivastava by procedure volume and prescribing
Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.
Dr. Geetika Srivastava has 6 publications on record
Dmand AI links 6 papers to Dr. Srivastava, published from 2013 to 2023. Dr. Srivastava's most frequent co-authors are Steven R. Alberts, MD, Robert J. Behrens, MD and George Paik Kim, MD.
Papers6
Years published2013 to 2023
Dr. Srivastava's papers by year, 2013 to 2023
Dr. Srivastava's most frequent co-authors
- Steven R. Alberts, MD2 shared papers
- Robert J. Behrens, MD2 shared papers
- George Paik Kim, MD2 shared papers
Recent publications by Dr. Srivastava
J Soc Cardiovasc Angiogr Interv
Eur Heart J
ChromonarCoronary CirculationEchocardiography
See who Dr. Srivastava researches with
Physician Network Discovery turns co-authorship, shared hospitals and shared groups into a map of who Dr. Srivastava works with, so you can find a warm path to the right hematologists and oncologists.
Sources: PubMed (National Library of Medicine); and Dmand AI Research Linkage
Dr. Geetika Srivastava has worked on 2 clinical trials
Dmand AI links Dr. Srivastava to 2 clinical trials. 1 is still active or recruiting. Conditions studied include Carcinoma, Renal Cell and Kidney Neoplasms.
Clinical trials with Dr. Srivastava by phase
- NonePhase 1: no trials
- 1Phase 1/2: 1 trial
- NonePhase 2: no trials
- 1Phase 3: 1 trial
- NonePhase 4: no trials
Conditions in Dr. Srivastava's trials
- Carcinoma, Renal Cell
- Kidney Neoplasms
Investigators on the most trials with Dr. Srivastava
Recent clinical trials with Dr. Srivastava
Phase I/II Study of Pembrolizumab and Cabozantinib in Patients With Metastatic Renal Cell Carcinoma (opens in a new tab)
CompletedPhase 1/2
Carcinoma, Renal CellKidney NeoplasmsCabozantinibPembrolizumab
Nivolumab in Treating Patients With Localized Kidney Cancer Undergoing Nephrectomy (opens in a new tab)
Active, not recruitingPhase 3
Carcinoma, Renal CellKidney NeoplasmsNivolumab
Sources: Dmand AI Research Linkage; and ClinicalTrials.gov (National Library of Medicine)
Dr. Geetika Srivastava received $18,953 in industry payments from 2016 to 2022
CMS Open Payments shows 35 general payments to Dr. Srivastava from 14 drug and device companies from 2016 to 2022. Consulting fees make up the largest share, 87% of the total. Bristol-Myers Squibb Company paid the most, $11,442.
General payments to Dr. Srivastava by program year, 2016 to 2022
General payments to Dr. Srivastava by kind, 2016 to 2022
$19Kin total
- Consulting fees$16,49787%
- Food and beverage$1,97910%
- Travel and lodging$4712%
- Education$70%
Companies that paid Dr. Srivastava the most, 2016 to 2022
Share is of all general payments to this clinician.
Source: Open Payments (CMS), 2025 data, released July 7, 2026
Sources for Dr. Geetika Srivastava's profile data
| Data on this page | Source |
|---|---|
| NPI, name, sex, specialty and licenses | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data |
| Practice locations and phone | Dmand AI Affiliation Data |
| Primary practice, affiliations and health system | Dmand AI Affiliation DataDmand AI Org Hierarchy Data |
| Medicare services and procedure codes | Medicare Physician & Other Practitioners - by Provider and Service (CMS) (opens in a new tab) |
| State medians for the same specialty | Dmand AI Peer Benchmarks |
| Medicare patients and the all-payer patient panel | Dmand AI Patient Panel Data |
| Part D prescribing | Medicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab) |
| Publications, topics and co-authors | PubMed (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage |
| Clinical trials and co-investigators | Dmand AI Research LinkageClinicalTrials.gov (National Library of Medicine) (opens in a new tab) |
| Industry payments | Open Payments (CMS) (opens in a new tab) |
| EHR at each practice site | Dmand AI Technology Install Data |
| Similar physicians | Dmand AI Affiliation Data |
Data last refreshed October 2026Report an inaccuracyRemove my information
FAQ
Frequently asked questions about Dr. Geetika Srivastava
Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.
What is Dr. Geetika Srivastava's NPI number?
Dr. Geetika Srivastava's NPI number is 1720296320. It was assigned on May 18, 2007, and it is active in the NPI Registry.
What kind of doctor is Dr. Geetika Srivastava?
Dr. Geetika Srivastava is a hematologist and oncologist in Washington, District of Columbia. The primary specialty in the NPI Registry is Hematology & Oncology Physician (taxonomy code 207RH0003X).
Where does Dr. Geetika Srivastava practice?
Dr. Srivastava practices at 50 Irving Street N.W., Washington, DC 20422. Dr. Srivastava's primary practice is Washington DC VA Medical Center in Washington, District of Columbia, part of Veterans Health Administration.
What is Dr. Geetika Srivastava's office phone number?
The practice phone on file for Dr. Srivastava is (202) 745-8000.
What is Dr. Geetika Srivastava's medical license number?
Dr. Srivastava holds Colorado license DR-52981.
Which hospitals is Dr. Geetika Srivastava affiliated with?
Dr. Srivastava practices at Washington DC VA Medical Center in Washington, District of Columbia.
Does Dr. Geetika Srivastava accept Medicare?
Yes. CMS data shows Dr. Srivastava billed Medicare for 137 services in 2022.
What services does Dr. Geetika Srivastava bill to Medicare?
In 2022, Dr. Srivastava's most billed Medicare services were office visit, established patient (99215), office visit, established patient (99214) and care management and other visits (99443).
What drugs does Dr. Geetika Srivastava prescribe most?
In 2022 Medicare Part D data, Dr. Srivastava's most prescribed drugs by claims were Letrozole and Tamoxifen Citrate.
Has Dr. Geetika Srivastava received payments from drug or device companies?
CMS Open Payments shows $18,953 in general payments to Dr. Srivastava from 14 companies from 2016 to 2022. The largest total came from Bristol-Myers Squibb Company.
Show 3 more questionsShow fewer questions
How long has Dr. Geetika Srivastava been practicing?
Dr. Srivastava graduated from medical school in 2005, 21 years ago.
Does Dr. Geetika Srivastava do research?
Dmand AI links 6 publications to Dr. Srivastava, published from 2013 to 2023. Dr. Srivastava has worked on 2 clinical trials.
Who does Dr. Geetika Srivastava publish with?
Dr. Srivastava's most frequent co-authors are Steven R. Alberts, MD (2 shared papers), Robert J. Behrens, MD (2 shared papers) and George Paik Kim, MD (2 shared papers).
Selling to hematology and oncology practices?
See hematologists and oncologists in District of Columbia by site of care and group
Find the practices, groups and hospitals they work with, and the right people to contact at each.
- 30 days free
- Self-serve
- No credit card